Veerix Biotech is a WHO-GMP certified third-party pharmaceutical manufacturer and CDMO partner producing VEERIX-DICLOFENAC Cream (DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ. TO DICLOFENAC SODIUM 1% W/W METHYL SALICYLATE IP 10% 1.16% W/W 1% W/W10% W/W MENTHOL IP 5% W/W LINSEED OIL BP 3% W/W THIOCOLCHICOSIDE IP 0.125% BENZYL ALCOHOL (AS W/W5% W/W 3% W/W0.125% PRESERVATIVE) IP 1% W/W GEL BASE Q.S) within the Pain Analgesics therapeutic class, with complete Certificate of Analysis (CoA), stability studies, and regulatory dossier compliance for domestic Indian and global export markets.
| Product Name | VEERIX-DICLOFENAC Cream |
| Active Composition | DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ. TO DICLOFENAC SODIUM 1% W/W METHYL SALICYLATE IP 10% 1.16% W/W 1% W/W10% W/W MENTHOL IP 5% W/W LINSEED OIL BP 3% W/W THIOCOLCHICOSIDE IP 0.125% BENZYL ALCOHOL (AS W/W5% W/W 3% W/W0.125% PRESERVATIVE) IP 1% W/W GEL BASE Q.S |
| Therapeutic Segment | Pain Analgesics |
| Dosage Form | Ointments |
| Primary Packaging | 15g / 30g |
| Quality Standard | IP / BP / USP Pharmacopeial Standard, WHO-GMP Certified |
| Manufacturing Facility | Tahliwal Industrial Area, Tehsil Haroli, Una, Himachal Pradesh & Coimbatore, Tamil Nadu |
| Regulatory Documentation | Batch Release CoA, Method of Analysis (MOA), Accelerated & Real-time Stability Data, CTD Module 3 |
Veerix Biotech provides end-to-end commercial supply and technical scoping for VEERIX-DICLOFENAC Cream in the Pain Analgesics class. From pre-formulation screening and pilot batch validation to automated blister packaging, serialisation, and multi-market regulatory clearance, our direct facilities and audited partner network ensure seamless execution.